https://www.taxtmi.com/caselaws?id=107956 The court dismissed the appeal against the rejection of the application opposing the Scheme of Demerger involving the Pharmaceutical Division. It found no merit in the allegations of uninformed consent of shareholders, disparate interests among shareholders, or invalidity of the share exchange ratio. The inclusion of clause 5.8 was deemed acceptable, and modifications made by the Company Court were within its jurisdiction. The court emphasized the shareholders' overwhelming approval, upheld the scheme's validity, and highlighted its supervisory role in approving schemes under statutory compliance and fairness principles. en-us Tue, 24 Apr 2001 00:00:00 +0530 Wed, 28 Mar 2012 10:38:25 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=107956 The court dismissed the appeal against the rejection of the application opposing the Scheme of Demerger involving the Pharmaceutical Division. It found no merit in the allegations of uninformed consent of shareholders, disparate interests among shareholders, or invalidity of the share exchange ratio. The inclusion of clause 5.8 was deemed acceptable, and modifications made by the Company Court were within its jurisdiction. The court emphasized the shareholders' overwhelming approval, upheld the scheme's validity, and highlighted its supervisory role in approving schemes under statutory compliance and fairness principles. Case-Laws Companies Law Tue, 24 Apr 2001 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=107956